Methods for enriching for pancreatic endocrine cells
First Claim
Patent Images
1. A method of enriching for cells expressing chromogranin A comprising:
- a) exposing an in vitro cell population comprising pancreatic chromogranin A positive cells to a ligand that binds CD200, CD318, CD142, CD57 or CD340; and
b) selecting cells from said in vitro cell population that express CD200, CD318 or CD57 or selecting cells from said in vitro cell population that do not express CD142 or CD340, thereby enriching for cells expressing chromogranin A.
1 Assignment
0 Petitions
Accused Products
Abstract
The present disclosure relates to compositions and methods comprising cell surface markers for hES-derived cells, in particular, endoderm lineage cells including pancreatic endoderm-type cells, derived from hES cells.
-
Citations
2 Claims
-
1. A method of enriching for cells expressing chromogranin A comprising:
-
a) exposing an in vitro cell population comprising pancreatic chromogranin A positive cells to a ligand that binds CD200, CD318, CD142, CD57 or CD340; and b) selecting cells from said in vitro cell population that express CD200, CD318 or CD57 or selecting cells from said in vitro cell population that do not express CD142 or CD340, thereby enriching for cells expressing chromogranin A. - View Dependent Claims (2)
-
Specification